Versant Capital Management, Inc Enanta Pharmaceuticals Inc Transaction History

Versant Capital Management, Inc

$454 Million
Q4 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$10.05 - $16.54 $361 - $595	36 Added 70.59%	87 $0
Q2 2024 Jul 05, 2024	SELL	$11.43 - $17.02 $205 - $306	-18 Reduced 26.09%	51 $0
Q4 2023 Jan 08, 2024	BUY	$8.18 - $10.78 $163 - $215	20 Added 40.82%	69 $0
Q3 2023 Oct 11, 2023	SELL	$11.09 - $22.13 $5,700 - $11,374	-514 Reduced 91.3%	49 $0
Q2 2023 Jul 10, 2023	BUY	$20.68 - $39.85 $9,471 - $18,251	458 Added 436.19%	563 $12,000
Q1 2023 Apr 10, 2023	SELL	$38.82 - $54.59 $271 - $382	-7 Reduced 6.25%	105 $4,000
Q4 2022 Jan 25, 2023	SELL	$40.77 - $53.73 $1,263 - $1,665	-31 Reduced 21.68%	112 $0
Q3 2022 Dec 30, 2022	BUY	$48.29 - $71.27 $1,883 - $2,779	39 Added 37.5%	143 $7,000
Q1 2022 Apr 29, 2022	SELL	$56.06 - $74.11 $2,298 - $3,038	-41 Reduced 28.28%	104 $7,000
Q3 2021 Oct 29, 2021	BUY	$41.02 - $58.65 $3,445 - $4,926	84 Added 137.7%	145 $8,000
Q2 2021 Jul 22, 2021	BUY	$43.76 - $53.11 $175 - $212	4 Added 7.02%	61 $3,000
Q1 2021 Apr 27, 2021	BUY	$41.69 - $54.95 $2,376 - $3,132	57 New	57 $3,000
Q2 2020 Jul 16, 2020	SELL	$46.37 - $57.58 $1,066 - $1,324	-23 Closed	0 $0
Q2 2019 Jul 16, 2019	SELL	$81.3 - $97.35 $3,333 - $3,991	-41 Reduced 64.06%	23 $1,000
Q1 2019 Apr 23, 2019	BUY	$69.08 - $105.66 $4,006 - $6,128	58 Added 966.67%	64 $6,000
Q1 2019 Apr 23, 2019	SELL	$69.08 - $105.66 $5,319 - $8,135	-77 Reduced 92.77%	6 $6,000
Q3 2017 Apr 23, 2018	SELL	$37.91 - $46.8 $2,881 - $3,556	-76 Reduced 47.8%	83 $3,000
Q2 2017 Apr 23, 2018	SELL	N/A	-11 Reduced 6.47%	159 $5,000
Q1 2017 Apr 23, 2018	SELL	N/A	-3 Reduced 1.73%	170 $5,000
Q3 2016 Apr 23, 2018	BUY	N/A	157 Added 981.25%	173 $4,000
Q2 2016 Apr 23, 2018	SELL	N/A	-138 Reduced 89.61%	16 $0
Q1 2016 Apr 23, 2018	BUY	N/A	115 Added 294.87%	154 $4,000
Q4 2015 Apr 23, 2018	BUY	N/A	39	39 $1,000

Others Institutions Holding ENTA

# of Institutions

111

Shares Held

21.2M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$10.5 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$9.87 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$9.2 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$7.46 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$5.49 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $103M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Account